Green Cross has ranked among the top-searched stocks for five days over the past month.


As of 12:30 p.m. on September 11, Green Cross is trading at 259,500 KRW, up 0.97% from the previous day. However, this represents a 13.79% decrease compared to August 19. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

Today, provisional data shows that foreign investors have made a net sale of 5,606 shares of Green Cross, while institutional investors have made a net purchase of 1,000 shares. Over the past five days, individual investors have made a net purchase of 150,484 shares, while foreign investors and institutional investors have made net sales of 146,110 shares and 1,419 shares, respectively.


On September 9, Green Cross became a market issue with the headline, "Have Expectations for COVID-19 Treatments Faded?... 8% Drop."





[Table] Net Buying/Selling Volume by Foreign and Institutional Investors (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was automatically generated in real time by a news creation algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist company.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing